Hepatitis C virus (HCV) affects 130-210 million people worldwide and is one of the major
risk factors for hepatocellular carcinoma. Globally, at least one third of hepatocellular …

The progression of fibrosis in chronic hepatitis C determines the ultimate prognosis and thus
the need and urgency of therapy. Fibrogenesis is a complex dynamic process, which is …

Background: Previous studies on the effect of interferon therapy on the incidence of
hepatocellular carcinoma have not sufficiently assessed degree of liver fibrosis, a major risk …

The prognosis of chronic hepatitis C virus (HCV) infection is still ill‐defined. The present
study prospectively evaluated mortality and complications in a large cohort of patients with …

The incidence of hepatocellular carcinoma is increasing in many countries. The estimated
number of new cases annually is over 500,000, and the yearly incidence comprises …

Hepatitis C virus (HCV) infection is now recognized to be a major risk factor for
hepatocellular carcinoma (HCC), evidenced by finding both antibody to HCV (anti-HCV) and …

BACKGROUND/AIMS: Hepatitis C virus (HCV) is a known risk factor for hepatocellular
carcinoma (HCC), but whether the risk varies among patients infected with different HCV …

To elucidate the risk factors for liver carcinogenesis and to examine the incidence of
hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients …

BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis
C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in …

BACKGROUND The severity, clinical course, and risk of hepatitis C virus (HCV) related
chronic liver disease are still rather poorly defined. AIMS To investigate the prevalence, risk …